🇺🇸 FDA
Patent

US 11337957

Compositions comprising urolithin compounds

granted A61KA61K31/366A61K47/14

Quick answer

US patent 11337957 (Compositions comprising urolithin compounds) held by Amazentis SA expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/366, A61K47/14, A61K47/24, A61K9/08